MedPath

Detection of Transplanted Heart Rejection by Blood Cell Gene Expression: a Novel Concept of Personalized Approach to Heart Transplantation Management

Not Applicable
Conditions
Post-cardiac transplantation allograft rejection management. (Determining the clinical validity of a novel method for early detection of transplant organ rejection).
Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system
Registration Number
ACTRN12611000008921
Lead Sponsor
Professor Igor Konstantinov
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

10 consecutive children aged 5-18 years undergoing heart transplantation and follow up clinical management at the Royal Children's Hospital, Melbourne.

Exclusion Criteria

Cardiac transplantation under age 5 and non-cardiac transplantation.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ongtitudinal changes in personalized gene expression pattern (Oligonucleotide Array changes) in peripheral blood with onset of rejection.[Baseline blood sample at heart transplantation, then at 4-6 week (approx monthly) endomyocardial biopsy during 1st year after transplantation (9 biopsies). (10 timepoint measures total).]
Secondary Outcome Measures
NameTimeMethod
il[Nil]
© Copyright 2025. All Rights Reserved by MedPath